Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Strong Trading Volume – Should You Buy?

Posted by Scott Moore on Aug 15th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 374,341 shares traded hands during mid-day trading, an increase of 144% from the previous session’s volume of 153,257 shares.The stock last traded at $13.76 and had previously closed at $13.59.

Analysts Set New Price Targets

A number of brokerages have commented on FSNUY. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Thursday, August 6th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.

View Our Latest Analysis on FSNUY

Fresenius SE & Co. Price Performance

The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The firm has a market cap of $30.86 billion, a PE ratio of 17.34 and a beta of 0.61. The stock has a 50 day moving average price of $12.17 and a two-hundred day moving average price of $12.75.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.91 billion during the quarter, compared to analysts’ expectations of $6.65 billion. Fresenius SE & Co. had a net margin of 6.67% and a return on equity of 10.33%. As a group, equities analysts expect that Fresenius SE & Co. will post 1.08 earnings per share for the current year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.